Dramatic response to nivolumab after local radiotherapy in pulmonary pleomorphic carcinoma with rapid progressive post-surgical recurrence

Abscopal, immunological effects of radiotherapy: Narrowing the gap between clinical and preclinical experiences

(2017) Nikko Brix et al.   IMMUNOLOGICAL REVIEWS

Pulmonary pleomorphic carcinoma with few PD-1-positive immune cells and regulatory T cells that showed a complete response to nivolumab

(2017) Kazuaki Okamura et al.   Thoracic Cancer

Case series of pleomorphic carcinomas of the lung treated with nivolumab

(2017) Masaki Kanazu et al.   Thoracic Cancer

High co-expression of PD-L1 and HIF-1α correlates with tumour necrosis in pulmonary pleomorphic carcinoma

(2016) Yih-Leong Chang et al.   EUROPEAN JOURNAL OF CANCER

Predictive Markers for the Efficacy of Anti–PD-1/PD-L1 Antibodies in Lung Cancer

(2016) Takehito Shukuya et al.   Journal of Thoracic Oncology

“Pseudoprogression” of Pulmonary Pleomorphic Carcinoma during Nivolumab Therapy

(2016) Kentaro Ito et al.   Journal of Thoracic Oncology

Current clinical trials testing the combination of immunotherapy with radiotherapy

(2016) Josephine Kang et al.   Journal for ImmunoTherapy of Cancer

Programmed death-1 ligand 1 and 2 are highly expressed in pleomorphic carcinomas of the lung: Comparison of sarcomatous and carcinomatous areas

(2015) Sehui Kim et al.   EUROPEAN JOURNAL OF CANCER

Immunogenic tumor cell death induced by chemoradiotherapy: molecular mechanisms and a clinical translation

(2013) K Kono et al.   Cell Death & Disease

Immunogenic Tumor Cell Death Induced by Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma

(2012) Yoshiyuki Suzuki et al.   CANCER RESEARCH

Pathology of Lung Cancer

(2011) William D. Travis   CLINICS IN CHEST MEDICINE

Pleomorphic Carcinoma of the Lung

(2008) Takahiro Mochizuki et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY